New insights into how β-cell subtypes influence diabetes risk and how maternal diet, epigenetics, and stem cell therapies may ...

Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health:In patients with type 2 diabetes (T2D) not achieving glycemic targets, ...

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and possibly discontinue medication, according to new ...

Enhancement in beta-cell function was correlated with an increase in the expression levels of the GLP-1 receptor as well as intracellular insulin – both transcript and protein levels were increased.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Patients with type 2 diabetes on a carbohydrate-restricted diet showed recovery in beta-cell function, researchers reported in The Journal of Clinical Endocrinology & Metabolism. “Beta-cell ...

Icovamenib improves beta cell function and insulin secretion, enhancing effectiveness of GLP-1 therapies in diabetes treatment. Quiver AI Summary Biomea Fusion, Inc. announced positive results ...

Now, the researchers have unlocked another, even more significant function of the receptor: it binds insulin and directs its breakdown within beta cells.

Adults were more likely to sustain glycemic control with each 5 kg weight loss achieved at 1 year (OR = 1.25; 95% CI, 1.05-1.49) and with every one standard deviation increase in homeostasis model ...